Buscar
🇪🇸
MEM
O
RY
.COM
4.37.48
Invitado
Iniciar sesión
Página de inicio
0
0
0
0
0
Crear curso
Cursos
Último juego
Panel
Notificaciones
Clases
Carpetas
Exámenes
Exámenes personalizados
Ayuda
Marcador
Tienda
Premios
Amigos
Asignaturas
Modo oscuro
Identificador de usuario: 999999
Versión: 4.37.48
www.memory.es
Estás en modo de exploración. debe iniciar sesión para usar
MEM
O
RY
Inicia sesión para empezar
Index
»
DRUG DISCOVERY DEVELOPMENT (DDD)
»
Clinical-Trials_-IND-Applications.pptx
»
Level 4
level: Level 4
Questions and Answers List
level questions: Level 4
Question
Answer
Can the Approval Process be shortened? What are the ways?
1 Fast Track 2 Breakthrough Therapy 3 Priority Review 4 Accelerated Approval FBPAge
A process designed to HELP SHORTEN THE TIME it takes to develop and review drugs that treat serious condition and FILL AN UNMET MEDICAL NEED.
Fast Track
The FDA can speed up the development and review of a drug if the EVIDENCE FROM EARLY CLINICAL TRIALS shows that it is a SUBSTANTIAL IMPROVEMENT compared with other available treatments.
Breakthrough Therapy
The FDA will aim to take action on an NDA within 6 months (compared with 10 months under standard review)
Priority Review
FDA regulation that allows EARLY APPROVAL for drugs that treat serious conditions or address an unmet medical need. Approval may be granted BASED ON A SURROGATE ENDPOINT.
Accelerated Approval